PRELUDE CAPITAL MANAGEMENT, LLC – Meridian Bioscience, Inc. Transaction History
PRELUDE CAPITAL MANAGEMENT, LLC portfolio value:
$2.39M
portfolio value
Meridian Bioscience, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | 0.00% | 76.02K shares | 2.39M | $31.53 | 76.02K |
| Q4 2020 | share | Decrease | -100.00% | -318 shares | -5K | $18.69 | 0 |
| Q3 2020 | share | Increase | +169.49% | 200 shares | 2K | $16.98 | 318 |
| Q2 2020 | share | Decrease | -94.69% | -2.10K shares | -16K | $23.29 | 118 |
| Q1 2020 | share | Increase | 0.00% | 2.22K shares | 19K | $8.4 | 2.22K |
| Q3 2019 | share | Decrease | -100.00% | -11.18K shares | -133K | $9.49 | 0 |
| Q2 2019 | share | Increase | 0.00% | 11.18K shares | 133K | $11.88 | 11.18K |
| Q1 2019 | share | Decrease | -100.00% | -752 shares | -13K | $17.61 | 0 |
| Q4 2018 | share | Decrease | -40.41% | -510 shares | -6K | $17.22 | 752 |
| Q3 2018 | share | Increase | +3.70% | 45 shares | 0 | $14.69 | 1.26K |
| Q2 2018 | share | Decrease | -81.07% | -5.21K shares | -72K | $15.54 | 1.21K |
| Q4 2017 | share | Decrease | -74.18% | -8.30K shares | -120K | $13.45 | 2.89K |
| Q3 2017 | share | Increase | +14.29% | 1.4K shares | 6K | $13.63 | 11.2K |
| Q2 2017 | share | Decrease | -61.56% | -15.69K shares | -198K | $14.87 | 9.8K |
| Q1 2017 | share | Increase | 0.00% | 25.49K shares | 352K | $12.92 | 25.49K |